SSRI antidepressant use patterns and their relation to clinical global impression scores: a naturalistic study

被引:3
作者
Hylan, TR [1 ]
Meneades, L
Crown, WH
Sacristan, JA
Gilaberte, I
Montejo, AL
机构
[1] Eli Lilly & Co, Global Hlth Econ Res, Indianapolis, IN 46285 USA
[2] Indiana Univ, Sch Publ & Environm Affairs, Indianapolis, IN 46204 USA
[3] MEDSTAT Grp, Cambridge, MA USA
[4] Lilly SA, Dept Clin Res, Madrid, Spain
[5] Hosp Univ, Salamanca, Spain
关键词
antidepressants; selective serotonin reuptake inhibitors; CGI-scale;
D O I
10.1016/S0165-0327(98)00064-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: A cascade of events follows initial antidepressant selection which includes the subsequent antidepressant use pattern, resultant clinical outcomes, and associated health care expenditures. Purpose: The purpose of this study using data from a clinical practice setting was to test whether the pattern of antidepressant use was correlated with patients' treatment response as measured by the score on the Clinical Global Impression-Improvement scale. Data and Method's: A retrospective dataset of patients who initiated therapy on fluoxetine, fluvoxamine, paroxetine, or sertraline in a primary care setting in Spain was used. A Cox proportional hazard analysis was used to predict the likelihood of treatment response based upon the pattern of initial antidepressant use, while minimizing the influence of other factors. Results: After controlling for other observed baseline characteristics including initial disease severity, (a) patients who remained on their initial antidepressant therapy for at least 2 months with no switching, augmentation, or upward dose titration were 1.63 times more likely to experience a treatment response than patients who had an adjustment to therapy; and (b) patients who initiated therapy on sertraline were 0.46 times as likely to experience a treatment response as patients who initiated therapy on the most common study antidepressant, fluoxetine. Conclusion: The pattern of antidepressant use is an important determinant of treatment response among patients initiating therapy on the newer antidepressants in clinical practice. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:111 / 119
页数:9
相关论文
共 38 条
[1]   THE EFFICACY OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN DEPRESSION - A METAANALYSIS OF STUDIES AGAINST TRICYCLIC ANTIDEPRESSANTS [J].
ANDERSON, IM ;
TOMENSON, BM .
JOURNAL OF PSYCHOPHARMACOLOGY, 1994, 8 (04) :238-249
[2]  
[Anonymous], 1989, J AFFECT DISORDERS, V17, P197
[3]   Antidepressant dose patterns in Swedish clinical practice [J].
Bingefors, K ;
Isacson, D ;
von Knorring, L .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1997, 12 (05) :283-290
[4]   Review of clinical use of sertraline by family practice physicians in a small Air Force hospital [J].
Bourgeois, MJA .
MILITARY MEDICINE, 1996, 161 (07) :425-427
[5]  
COX DR, 1972, J R STAT SOC B, V34, P187
[6]  
Croghan TW, 1997, PSYCHIATR SERV, V48, P1420
[7]  
DONOGHUE JM, 1996, BRIT MED J, V313, P811
[8]  
DONOGHUE JM, 1996, J SEROTON RES, V4, P267
[9]  
EKSELIUS L, 1997, EUR NEUROPSYCHOPHA S, V7, pS147, DOI DOI 10.1016/S0924-977X(97)88489-1
[10]  
GREENE WH, 1995, ECONOMETRIC ANAL